Browsing Tag
chronic kidney disease
25 posts
AstraZeneca to acquire US biopharma company CinCor Pharma for $1.8bn
AstraZeneca has agreed to acquire CinCor Pharma for a transaction value of around $1.8 billion, which includes an…
AstraZeneca Pharma India gets Dapagliflozin 10mg import and market permission from CDSCO
AstraZeneca Pharma India has secured an import and market permission for Dapagliflozin (Forxiga) tablets of 10 mg from…
Cara Therapeutics, VFMCRP get EC approval for Kapruvia for pruritus
Cara Therapeutics and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) said that Kapruvia (difelikefalin) has secured approval from…
Japan approves Roxadustat for non-dialysis anemia in chronic kidney disease
Astellas Pharma and FibroGen have received approval from Japan’s Ministry of Health, Labour and Welfare (MHLW) for the…
AstraZeneca’s Farxiga receives FDA breakthrough therapy designation for chronic kidney disease treatment
AstraZeneca’s Farxiga (dapagliflozin), a leading drug in the management of chronic kidney disease (CKD), has been granted Breakthrough…